{"id":"https://openalex.org/W26863458","doi":null,"title":"Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.","display_name":"Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.","publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W26863458","mag":"26863458","pmid":"https://pubmed.ncbi.nlm.nih.gov/11314240"},"language":"en","primary_location":{"id":"pmid:11314240","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11314240","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology research","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056205020","display_name":"Gamal Ahmed Duweb","orcid":"https://orcid.org/0009-0005-5703-5700","observed_orcids":["https://orcid.org/0009-0005-5703-5700"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G A Duweb","raw_affiliation_strings":["Dermatology Department, Faculty of Medicine, Al-Tahadi University, Sirte, Libya. gamal_a_duweb@hotmail.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dermatology Department, Faculty of Medicine, Al-Tahadi University, Sirte, Libya. gamal_a_duweb@hotmail.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016197546","display_name":"O Abuzariba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Abuzariba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Rahim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Rahim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M al-Taweel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M al-Taweel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035838150","display_name":"Sonya Abdulla","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S A Abdulla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1131,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.4156231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"20","issue":"3-4","first_page":"65","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/scalp-psoriasis","display_name":"scalp psoriasis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/calcipotriol","display_name":"calcipotriol","score":0.9929999709129333},{"id":"https://openalex.org/keywords/betamethasone-valerate","display_name":"betamethasone valerate","score":0.996999979019165},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.8550000190734863},{"id":"https://openalex.org/keywords/vitamin-d-analogs","display_name":"vitamin D analogs","score":0.6549999713897705},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8619999885559082}],"concepts":[{"id":"https://openalex.org/C2776009542","wikidata":"https://www.wikidata.org/wiki/Q155683","display_name":"Calcipotriol","level":3,"score":0.9739208817481995},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9161094427108765},{"id":"https://openalex.org/C2780986958","wikidata":"https://www.wikidata.org/wiki/Q1871151","display_name":"Lotion","level":2,"score":0.8036491870880127},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7329972386360168},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6550906300544739},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6256672739982605},{"id":"https://openalex.org/C2781162121","wikidata":"https://www.wikidata.org/wiki/Q416132","display_name":"Betamethasone","level":2,"score":0.5754570960998535},{"id":"https://openalex.org/C2779121184","wikidata":"https://www.wikidata.org/wiki/Q1166142","display_name":"Erythema","level":2,"score":0.5612488389015198},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.5589668154716492},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4951418936252594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23055818676948547},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.17352181673049927}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001624","descriptor_name":"Betamethasone Valerate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012536","descriptor_name":"Scalp Dermatoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:11314240","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11314240","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology research","raw_type":"Clinical Trial"},{"id":"mag:26863458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11314240","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W118664736"],"related_works":["https://openalex.org/W2092916329","https://openalex.org/W2079101710","https://openalex.org/W1974724279","https://openalex.org/W2157872331","https://openalex.org/W2025490383","https://openalex.org/W2414403220","https://openalex.org/W4238976498","https://openalex.org/W2075779007","https://openalex.org/W1600088935","https://openalex.org/W2163031644"],"abstract_inverted_index":{"Forty-two":[0],"patients":[1,22,142,153,205,238],"aged":[2],"between":[3],"6":[4,80,120],"and":[5,26,42,107,115,119,129,147,172,190,218,226],"61":[6],"years":[7],"(mean:":[8],"33.5":[9],"years)":[10],"with":[11,67],"psoriasis":[12,59,90,234],"of":[13,33,44,58,60,71,89,113,121,134,139,150,182,214,232],"the":[14,39,56,61,68,111,132,140,144,151,156,169,175,180,208,230],"scalp":[15,233],"were":[16,24,29,95,197,224],"enrolled":[17],"in":[18,55,136,143,148,155,168,174,199,203,207,229,236],"this":[19,184],"study.":[20],"Twenty-seven":[21],"(69%)":[23],"males":[25],"15":[27,137],"(31%)":[28],"females.":[30],"The":[31,63,123,159],"aim":[32],"our":[34],"study":[35,64],"was":[36,65,84,108,166,186],"to":[37,101,188,241],"evaluate":[38],"efficacy,":[40],"safety":[41],"tolerability":[43],"topical":[45],"calcipotriol":[46,73,145,170,209,239],"50":[47],"micrograms/g/ml":[48],"solution":[49,74],"vs.":[50],"betamethasone":[51,76,157,176],"valerate":[52,77,177],"1%":[53],"lotion":[54,78],"treatment":[57,114,135,231],"scalp.":[62],"randomized":[66],"twice-daily":[69],"application":[70],"either":[72,200],"or":[75],"for":[79,244],"weeks.":[81],"Treatment":[82],"evaluation":[83],"clinically":[85],"based":[86],"on":[87],"signs":[88,213],"(thickness,":[91],"redness,":[92],"scaliness)":[93],"which":[94],"scored":[96],"from":[97],"0":[98],"=":[99,103],"absent":[100],"4":[102],"severest":[104],"possible":[105],"involvement":[106],"performed":[109],"at":[110,116,131,164],"start":[112],"weeks":[117],"2":[118],"treatment.":[122],"results":[124],"showed":[125],"a":[126],"marked":[127],"improvement":[128],"clearance":[130],"end":[133,181],"(72.8%)":[138],"24":[141],"group":[146,171,201,210],"13":[149],"18":[152],"(72%)":[154],"group.":[158,178],"mean":[160],"total":[161],"sign":[162],"score":[163,185],"baseline":[165],"5.1":[167],"5.4":[173],"At":[179],"treatment,":[183],"decreased":[187],"2.1":[189],"1.49,":[191],"respectively.":[192],"No":[193],"significant":[194],"adverse":[195],"effects":[196],"reported":[198],"except":[202],"two":[204],"(8.3%)":[206],"who":[211],"developed":[212],"irritation":[215],"including":[216],"itching":[217],"erythema.":[219],"In":[220],"conclusion,":[221],"both":[222],"drugs":[223],"effective":[225],"well":[227],"tolerated":[228],"but":[235],"some":[237],"had":[240],"be":[242],"given":[243],"more":[245],"prolonged":[246],"courses.":[247]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}